What is Akesis?
Akesis is dedicated to making life-saving radiation medicine accessible to all. The company is engineering cutting-edge stereotactic radiosurgery and linear accelerator systems, distinguished by patented continuous 360-degree rotational technology and real-time, in-line imaging. By integrating advanced technological features with established treatment methodologies, Akesis aims to redefine the landscape of Radiation Medicine. Manufacturing operations are based in the United States at their facility near San Francisco, California. The company's flagship products, the Akesis Galaxy RTi and Gemini360, are currently under development and not yet available for commercial sale.
How much funding has Akesis raised?
Akesis has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Akesis?
The recent major strategic investment signals a critical phase of scaling and market penetration for Akesis. As a company operating in the late-stage funding environment, this capital infusion is likely earmarked for accelerating product commercialization, expanding manufacturing capabilities, and broadening its market reach. Akesis's focus on innovative technology in radiation medicine positions it to capture a significant share of a growing healthcare sector, contingent on successful regulatory approvals and market adoption.
See full Akesis company page
